BridgeBio Pharma (BBIO) Research & Development (2018 - 2026)
BridgeBio Pharma's Research & Development came in at $143.51 million for Q3 2026, up 27.1% from $112.87 million a year earlier but down 4.0% from the prior quarter.
Powered by 
Analysis
BridgeBio Pharma (BBIO) Research & Development (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, BridgeBio Pharma reported Research & Development of $536.01 million, up 15.1% year-over-year; for FY2025, it came in at $451.95 million, down 10.8% from FY2024.
- Research & Development carries a five-year compound annual growth rate of 6.0% (FY2020 to FY2025).
- Going back by year, Research & Development was $506.46 million in FY2024 (+11.1%), $455.71 million in FY2023 (+14.1%), $399.46 million in FY2022 (-11.4%) and $451.02 million in FY2021 (+33.8%).
- The five-year range for quarterly Research & Development is $90.9 million (Q4 2022) to $149.45 million (Q2 2026).
- Year-over-year, Research & Development has increased for three consecutive quarters, with growth averaging 4.3% over the last eight quarters.
- The fastest year-over-year change in Research & Development over five years came in Q1 2024 (growth of 51.8%), and the weakest in Q4 2022 (a decline of 25.6%).
- Business Quant data shows BBIO's Research & Development at $149.45 million (Q2 2026), $126.64 million (Q1 2026) and $116.42 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.02 Bn |
| 10 | BridgeBio Pharma | 15.42 Bn | 11.64 Bn | 332.72 Mn | 143.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 143.51 Mn |
| Jun 30, 2026 | 149.45 Mn |
| Mar 31, 2026 | 126.64 Mn |
| Dec 31, 2025 | 116.42 Mn |
| Sep 30, 2025 | 112.87 Mn |
| Jun 30, 2025 | 111.23 Mn |
| Mar 31, 2025 | 111.43 Mn |
| Dec 31, 2024 | 130.35 Mn |
| Sep 30, 2024 | 120.44 Mn |
| Jun 30, 2024 | 114.70 Mn |
| Mar 31, 2024 | 140.97 Mn |
| Dec 31, 2023 | 130.23 Mn |
| Sep 30, 2023 | 125.14 Mn |
| Jun 30, 2023 | 107.49 Mn |
| Mar 31, 2023 | 92.86 Mn |
| Dec 31, 2022 | 90.90 Mn |
| Sep 30, 2022 | 92.51 Mn |
| Jun 30, 2022 | 108.40 Mn |
| Mar 31, 2022 | 107.65 Mn |
| Dec 31, 2021 | 122.20 Mn |
API Access
BridgeBio Pharma Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=BBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();